VARDENAFIL

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1515060
                    [Title] => Intimate questions about love and sex
                    [Summary] => 
Recently, I have been getting many questions regarding love, sex, and impotence.

                    [DatePublished] => 2015-10-26 10:00:00
                    [ColumnID] => 134789
                    [Focus] => 0
                    [AuthorID] => 1805275
                    [AuthorName] => Dr. Willie T. Ong
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 264734
                    [Title] => Wonder-drug designed for sexual wellness
                    [Summary] => The truth about male sexuality is hard to swallow. 


                    [DatePublished] => 2004-09-14 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1804862
                    [AuthorName] => Igan D’Bayan
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 242151
                    [Title] => New treatment for erectile difficulty bared
                    [Summary] => A new treatment for erectile dysfunction or erection difficulty (ED) – a condition that affects an estimated 152 million men worldwide – was recently introduced by Bayer AG of Germany and GlaxoSmithKline (GSK).


Vardenafil, marketed by Bayer Philippines Inc. and GSK Philippines Inc., has been proven in many clinical trials worldwide to be a safe and reliable treatment for ED, a condition that plagues over half of all men above age 40. 


                    [DatePublished] => 2004-03-11 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 152317
                    [Title] => Giant German pharma set to launch newest  anti-"ED" preparation
                    [Summary] => Leverkusen, Germany - First Pivotal Phase III data for vardenafil,  Bayer’s new,  highly selective phosphodiesterase-5 inhibitor for erectile dysfunction (ED),  show statistically significant improvements in erectile function and consistency in response among up to 85 percent of the broad population of men treated.  The data was presented last December at the Annual Meeting of the Sexual Medicine Society of North America (SMSNA) in Charleston,  South Carolina/USA.


                    [DatePublished] => 2002-03-01 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

abtest

Intimate questions about love and sex

By Dr. Willie T. Ong | October 26, 2015 - 10:00am

Recently, I have been getting many questions regarding love, sex, and impotence.

Health And Family

Wonder-drug designed for sexual wellness

By Igan D’Bayan | September 14, 2004 - 12:00am

The truth about male sexuality is hard to swallow.

Health And Family

New treatment for erectile difficulty bared

March 11, 2004 - 12:00am

A new treatment for erectile dysfunction or erection difficulty (ED) – a condition that affects an estimated 152 million men worldwide – was recently introduced by Bayer AG of Germany and GlaxoSmithKline...

Science and Environment

Giant German pharma set to launch newest anti-"ED" preparation

March 1, 2002 - 12:00am

Leverkusen, Germany - First Pivotal Phase III data for vardenafil, Bayer’s new, highly selective phosphodiesterase-5 inhibitor for erectile dysfunction (ED), show statistically significant improvements in...

Health And Family